Quantitation of Pretreatment Serum Interferon-gamma-Inducible Protein-10 Improves the Predictive Value of an IL28B Gene Polymorphism for Hepatitis C Treatment Response
Jama M Darling, Jeroen Aerssens, Gregory Fanning, John G McHutchison, David B Goldstein, Alexander J Thompson, Kevin V Shianna, Nezam H Afdhal, Michael L Hudson, Charles D Howell, Willem Talloen, Jacques Bollekens, Mieke De Wit, Annick Scholliers, Michael W Fried
Hepatology | WILEY-BLACKWELL | Published : 2011
Awarded by National Institutes of Health
Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
The VIRAHEP-C study was conducted by multiple investigators and supported by the National Institute of Digestive and Kidney Diseases (NIDDK). This manuscript was not prepared in collaboration with the investigators of VIRAHEP-C and does not necessarily reflect the opinions or views of the VIRAHEP-C study or the NIDDK. The authors would like to thank the VIRAHEP-C investigators and the NIDDK Biospecimen Repository.Supported in part by National Institutes of Health Mid-Career Mentoring Award K24 DK066144 (to M. W. Fried).